The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy
Authors:
- Arlene M. CorreaACArlene M. Correa
- Ritsuko KomakiRKRitsuko Komaki
- Joe Y. ChangJCJoe Y. Chang
- Anne S. TsaoATAnne S. Tsao
- Jack A. RothJRJack A. Roth
- Stephen G. SwisherSSStephen G. Swisher
- David C. RiceDRDavid C. Rice
- Ara A. VaporciyanAVAra A. Vaporciyan
- Steven H. LinSLSteven H. Lin
- 1 September 2012
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 94 (3) , 914-920
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2012
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non–Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901Journal of Clinical Oncology, 2007
- Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935Journal of Surgical Oncology, 2006
- Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyBritish Journal of Cancer, 2006
- Phase II Trial of Postoperative Adjuvant Paclitaxel/Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non–Small-Cell Lung Cancer: Promising Long-Term Results of the Radiation Therapy Oncology Group—RTOG 9705Journal of Clinical Oncology, 2005
- Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II TrialJournal of Clinical Oncology, 2003
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Effectiveness of Postoperative Irradiation in Stage IIIA Non–Small Cell Lung Cancer According to Regression Tree Analyses of Recurrence RisksThe Annals of Thoracic Surgery, 1997
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI: Journal of the National Cancer Institute, 1994